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INTRODUCTION 
Veda is an ancient scientific document from which 
every science and technology has originated.  
Ayurveda is Upaveda of Atharvaveda. The 
fundaments  of   Ayurveda   give  healthy  human  life. 
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Health is one of the important requirements to 
achieve Purusartha Chatushtaya. Dhatu Samyata is 
the sign of health. Fast foods, lack of exercise, stress, 
various addictions etc. are some of the factors which 
contribute greatly to such diseases. These factors 
generally act by impairing the metabolism of an 
individual making him prone to series of disorders. 
Dyslipidemia is one such disorder which is identified 
as a potential risk factor for multitudes of diseases like 
cardiovascular diseases, metabolic syndrome and 
even hypertension. A study conducted by ICMR in 
India showed 13.9% had hypercholesterolemia, 29.5% 
had Hyper-triglyceridemia, 72.3% had low HDL-C, 
11.8% had high LDL-C levels and 79% had 
abnormalities in one of the lipid parameters. Urban 
residents had the highest prevalence of lipid 
abnormalities compared to rural residents.
[1] 
Ayurveda 
emphasis on different Shamana Yogas for the 
treatment of Meda Slesmavikaras.  Vikrut Meda 
A B S T R A C T  
Dyslipidemia is a disorder of lipoprotein metabolism, including lipoprotein over production or 
deficiency. Dyslipidemia may be manifested by elevation of total cholesterol, LDL cholesterol and 
triglycerides concentration and decrease in HDL cholesterol concentration in the blood i.e. presence of 
one or more than one abnormal serum lipid concentration. Dyslipidemia has becoming one of the 
major problems leading to various disorders like obesity, diabetes, atherosclerosis, cerebrovascular 
diseases, hypertension etc. Dyslipidemia is a condition which shares a lot of similarity in pathogenesis 
and clinical presentation of Medoroga. Medoroga is a condition in which there is abnormal and unequal 
distribution and collection of Medo Dhatu in body. In the comprehensive Ayurvedic literature Medoroga 
has been synonymously described as Sthoulya, which has been classified under Ashta Nindita 
Purusha. The incidence and the magnitude of the problem are constant rise due to alternation in 
lifestyle with sedentary habits, overeating and stressful life environmental factors etc. The treatment 
strategy is to implement lifestyle changes including diet and exercise, weight loss and lipid lowering 
drugs. In spite of availability of numerous drugs, mankind is still leading miserable life with this 
disease. Hence Ayurveda emphasizes natural and effective remedies which are cost effective and 
helpful in prevention of the disease. There are variety of drugs mentioned for Medodushti and 
Atisthoulya. Haritaki and Madhu is one such combination explained in Samhita. 
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Slesma can be correlated with pathophysiology of 
dyslipidemia. There are variety of drugs mentioned 
for Medodushti and Atisthoulya. Haritaki and Madhu 
is one combination explained in Samhita.
[2]
 Haritaki is 
said to be Pathyatama in Agrya Prakarana. Madhu is 
also a drug advised as a Nityasevaniyadravya. Both 
the drugs are individually Medohara due to their 
inherent qualities. Considering Medodushti in 
parlance with Dyslipidemia the study is planned to 
experimentally evaluate the Antidyslipidemic activity 
of Haritaki and Madhu in albino rets. 
OBJECTIVES 
To evaluate the Antidyslipidemic effect of Haritaki and 
Madhu in Albino rats. 
MATERIALS AND METHOD 
Study design 
It is a randomised experimental trail. The selected 
albino rats have been grouped into 5 groups with 6 
animals in each group. In group 1 only water and 
normal diet has been administered without 
Hyperlipidemic diet, whereas group 2 receive only 
Hyperlipidemic diet. 3, 4 and 5 have received the drug 
and diet for 27 days as per table. On 28th day, after 
overnight fasting, the rats had been sacrificed. Blood 
will be collected from retro-orbital puncture and 
assigned for biochemical investigation. The liver, 
kidney and heart excised out from sacrificed animal, 
weighed and transferred to fixing solution (10% 
formalin) for Histopathological examinations. 
Table 1: Grouping of the animal  
Drug selection 
1. Haritaki Churna was purchased from SDM 
Pharmacy Udupi for the study. 
2. Madhu was collected from Brahmavara and 
authentication done in SDM Research Lab. 
Dose for Animals: Human dose x 0.018 x 5 / Kg wt 
Dose for rats: Human dose x 0.018 x 5 x wt of the rat / 
1000 g 
Dose of Haritaki Choorna - 12g ×0.018×5 
                                                = 1.08g / kg 
Dose of Madhu = 1ml /100g 
Dose of cholesterol = 1ml /100g 
Route of drug administration 
The test drugs were administered according to the 
body weight of the animals by oral route with the help 
of gastric catheter. 
Inclusion criteria 
Not less than eight week old healthy albino rats of 
either sexes weighing about 150-250g were selected 
in random. 
Exclusion criteria 
Diseased rats, rats under trail for other experiments, 
pregnant rats and rats below 150g and more than 
250g 
Parameters studied 
Ponderable changes 
Body weight, weight of organs like Heart, Liver and 
kidney were recorded and expressed in terms of 
relative values. 
Clinical chemistry 
From the blood collected from the orbital plexuses 
serum would be separated and analysed for the 
following parameters in each animal (collected at the 
end of the study or at the time of sacrificing moribund 
or intercurrently ill animals. The animals would be 
subjected to overnight fasting). 
Serum Bio-Chemical Parameters 
For estimation of bio-chemical parameters, serum 
was separated from collected blood and requisite 
Group 
No. of 
rats 
Drugs 
1 6 Normal diet  
2 6 High cholesterol diet  
3 6 
Atorvastatin with high cholesterol 
diet. 
4 6 
Haritaki and Madhu with high 
cholesterol diet  
5 6 Madhu with high cholesterol diet 
Krunalsinh Thakor et.al. A Study on Anti Dyslipidemia Activity of Haritaki and Madhu. 
ISSN: 2456-3110                                                    ORIGINAL ARTICLE Jan-Feb 2017 
 
Journal of Ayurveda and Integrated Medical Sciences | Jan - Feb 2017 | Vol. 2 | Issue 1 80 
 
quantity of serum was fed to the auto analyser which 
was automatically drawn into the instrument for 
estimating different parameters. Bio-chemical 
parameters like Serum Cholesterol, Serum 
Triglycerides, Serum HDL-cholesterol, Serum LDL-
cholesterol, Serum Urea, Serum Creatinine, Serum 
Glutamic oxaloacetic transaminase(SGOT), Serum 
glutamic pyruvic transaminase (SGPT) activity, Total 
Protein, Serum Albumin, Serum Globulin, Serum 
Alkaline phosphatise activity, Total bilirubin, Direct 
Bilirubin were estimated. 
Statistical Analysis  
The data generated was analysed by employing one 
way ANOVA with Dunnet’s multiple ‘t’ test as post hoc 
test. 
OBSERVATIONS AND RESULTS 
Table 2: Effect of Haritaki and Madhu on serum 
cholesterol level. 
Groups 
Cholesterol 
(mg/100ml) 
% change 
Normal control 52.66 ± 4.31 - 
Cholesterol control 98.5 ± 5.22** 87.04↑@ 
Standard  65.66 ± 3.90** 33.34↓# 
H+ M 54 ± 4.56** 45.17↓# 
M 102.8 ± 10.06 4.36↑# 
Data: MEAN ± SEM, **P<0.01, H+M = Haritaki 
+Madhu, Standard = Atorvastatin, M = Madhu. @-
compared with normal control, #-compared with 
cholesterol control 
The data shows that due to hyperlipidemic diet there 
was an increase in serum cholesterol level in 
cholesterol control group when compared to the 
normal control group. The observed increase was 
found to be statistically very significant. 
The data shows there was a decrease in serum 
cholesterol level in standard group and H+M group 
when compared to the cholesterol control group. The 
observed decrease was found to be statistically very 
significant. 
Table 3:  Effect of Haritaki and Madhu on 
Triglyceride level. 
Groups 
Triglyceride 
(mg /100ml.) 
% change 
Normal control 89.5 ± 5.70 - 
Cholesterol control 235± 40.70* 162.56↑@ 
Standard  214.6± 47.55 8.56↓# 
H+ M 116.5 ± 29.97 50.42↓# 
M 266 ± 43.09 13.19↑# 
The data shows that due to hyperlipidemic diet there 
was an increase in Serum Triglycerides level in 
cholesterol control group when compared to the 
normal control group. The observed increase was 
found to be statistically significant. 
The data shows there was a decrease in serum 
Triglycerides level in standard group and H+M group 
when compared to the cholesterol control group. The 
observed decrease was found to be statistically not 
significant. (Table 3) 
Table 4:  Effect of Haritaki and Madhu on HDL 
cholesterol level. 
Groups 
HDL Cholesterol 
(mg/100ml) 
% change 
Normal control 26.83 ± 3.26 - 
Cholesterol control 34.5± 2.81 28.56↑@ 
Standard  46.33± 4.0 34.28↑# 
H+ M 34 ± 4.27 1.44↓# 
M 32.2 ± 1.80 6.66↓# 
The data shows that due to hyperlipidemic diet there 
was an increase Serum HDL cholesterol level in 
cholesterol control group when compared to the 
Krunalsinh Thakor et.al. A Study on Anti Dyslipidemia Activity of Haritaki and Madhu. 
ISSN: 2456-3110                                                    ORIGINAL ARTICLE Jan-Feb 2017 
 
Journal of Ayurveda and Integrated Medical Sciences | Jan - Feb 2017 | Vol. 2 | Issue 1 81 
 
normal control group. The observed increase was 
found to be statistically not significant. 
The data shows there was an increase in serum HDL 
cholesterol level in standard group and decrease in 
H+M group when compared to the cholesterol control 
group. The observed decrease was found to be 
statistically not significant. 
Table 5: Effect of  Haritaki and Madhu on LDL 
cholesterol level. 
Groups 
LDL cholesterol 
(mg/100ml) 
% change 
Normal control 17 ± 1.21 - 
Cholesterol control 23.5 ± 2.24 38.23↑@ 
Standard  12.33 ± 1.11** 47.53↓# 
H+ M 11.88 ± 2.40** 49.44↓# 
M 27.2 ± 3.05 15.74↑# 
The data shows that due to hyperlipidemic diet there 
was an increase serum LDL   cholesterol level in 
cholesterol control group when compared to the 
normal control group. The observed increase was 
found to be statistically not significant.The data shows 
there was a decrease in serum LDL cholesterol level in 
standard group and H+M group when compared to 
the cholesterol control group. The observed decrease 
was found to be statistically very significant 
Table 6: Effect of Haritaki and Madhu on VLDL 
cholesterol level. 
Groups 
VLDL cholesterol 
(mg/100ml) 
% change 
Normal control 17.9± 1.14 - 
Cholesterol control 46.5 ± 8.21* 159.77↑@ 
Standard  42.66 ± 9.52 8.25↓# 
H+ M 23.4 ± 5.87 49.67↓# 
M 53 ± 8.83 13.97↑# 
The data shows that due to hyperlipidemic diet there 
was an increase serum VLDL cholesterol   level in 
cholesterol control group when compared to the 
normal control group. The observed increase was 
found to be statistically significant. 
The data shows there was a decrease in serum VLDL 
cholesterol level in standard group and H+M group 
when compared to the cholesterol control group. The 
observed decrease was found to be statistically not 
significant 
Table 7: Consolidated statement of biochemical 
parameters on administration of Haritaki and 
Madhu. 
Paramet
ers 
Compared
with 
normal 
control 
Compared with cholesterol 
control 
Cholesterol 
control 
Choleste
rol + 
Standar
d 
Choleste
rol  + 
Haritaki 
+ Madhu 
Choleste
rol  + 
Madhu 
Serum 
cholester
ol 
SI SD SD SI 
Triglyceri
de  
SI NSD NSD NSI 
HDL NSI NSI NSD NSD 
LDL NSI SD SD NSI 
VLDL SI NSD NSD NSI 
Serum 
Urea   
SD NSD NSD NSD 
Serum 
Creatinin
e 
SD NSD NSD NSE 
 
B. Sugar NSI NSD NSI NSD 
SGOT 
Activity 
NSI NSD NSI NSI 
SGPT SI NSD NSD NSI 
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Activity 
ALP 
Activity 
SI NSD NSD NSD 
Total 
protein 
SI NSD NSD NSD 
Albumin NSD NSD NSD NSD 
Globulin SI NSD NSD NSD 
Indirect 
bilirubin 
SI NSE NSD NSI 
Direct 
bilirubin 
SI NSD NSI NSI 
Liver 
weight 
NSD NSI NSI NSI 
Heart 
weight 
NSI SI NSI NSI 
Kidney 
weight 
SD SI NSI NSI 
SD - Significantly decrease, SI - Significantly increase, NSI - 
NonSignificantly increase, NSD - Non Significantly decrease 
DISCUSSION 
Any theory or observation emerged from classical and 
experimental study can only be accepted if there is 
proper reasoning (Tarka) of the observations. 
According to ancient research methodology, before 
establishing any theory, Upanaya (Discussion) is prior 
step to Nigamana (Conclusion). Discussion is a 
process of re-examining and forms the base for 
conclusion. Inspite of detailed literature and 
experimental study, a theory is accepted only after 
the proper reasoning of observation. Acharyas used 
their way of experimentation and researches during 
their period for the upliftment of our science. Charaka 
says in Sutrasthana 10th chapter that those alone are 
wise who act after investigation. Even he mentioned 
about testing drugs and food in animals before 
administering to human. Sushruta Samhita has dealt 
with animal experiment by devoting a separate 
chapter -Yogya Vidhi. It is said that any procedure, 
which is to be performed on human being, should 
undergo trial on animals or other things, having 
similar characteristics. Also in Kalpasthana of Sushruta 
Samhita there is similar discussion dealing with the 
observations of animal experiments. Hence before 
administering any drug to human it is desirable to 
experiment the same on lower animals. 
Thus for scientific explanation of any phenomena 
experimentation is necessary. Although the richness 
and potential of Ayurveda is well known even to 
common people, it is always considered better to 
establish such a knowledge based on experimental 
findings, which is the master key to make such 
knowledge widespread, to shows its depth of 
understanding and acceptable to all over the world. 
There are many concepts in Ayurveda which need 
detailed scrutiny to assess their utility in the field of 
science. Among them one concept is Sthoulya. 
Sthoulya is the major issue which this era is facing. 
This is mainly due to our lifestyles and food habits. 
Effect of Haritaki and Madhu on ponderable 
changes. 
In observation it’s found that stool of Haritaki and 
Madhu group was dry compared to other group. 
Positive control group stool was unctuous and loose in 
nature. Weight of positive control group rats was 
increased compare to Haritaki and Madhu group. In 
dissection observed more fat deposition in the 
omentum of positive control group. In Haritaki and 
Madhu group it is significantly reduced. Also more 
water uptake by the Haritaki and Madhu group was 
observed compared to other groups. 
Effect of Haritaki and Madhu on lipid profile 
Administration of hyperlipidemic diet lead to 
significant elevation in serum total cholesterol, serum 
triglyceride level, LDLand VLDL cholesterol and 
decrease in HDL cholesterol. These hyperlipidemic 
diet induced changes were significantly reversed by 
the administration of Haritaki and Madhu, thus 
providing evidence for its efficacy in reversing the 
dyslipidaemia induced changes. This can be done by 
focusing on the mechanisms of action of atorvastatin. 
Atorvastatin are competitive inhibitors of HMG-CoA 
reductase, the rate limiting step in cholesterol 
synthesis. Haritaki contains alkaloids phytosterols, 
saponins, tannins, ellagic acid, gallic acid, chebulinic 
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acid, chebugalic acid and corilagin. High amount of 
saponins, phytosterols, chebulinic acid and corilagin 
present in Haritaki may be responsible for the 
hypolipidemic effect. Anti-oxidant constituents of 
Haritaki and Madhu also prevent the endogenous 
oxidation of cholesterol resulting in decrease in the 
concentration of low density lipoprotein and again 
confirm the hypolipidemic activity. Tannins have been 
reported to increase faecal bile acid excretion, 
thereby leading to reduction in cholesterol levels. 
As part of biomarkers assessment protein, serum 
albumin, SGOT, SGPT activity was measured as an 
index of liver function along with serum bilirubin level, 
serum urea and creatinine activity was assessed as a 
measure of kidney function. Disturbance in the tissue 
integrity especially of liver would get reflected in the 
form of elevation. The serum SGPT and ALPase 
activity were found to be significantly elevated due to 
hyperlipidemic diet. SGOT activity was also elevated 
but did not reach statistically significant level. 
In present study also impaired bile pigment 
metabolism was seen, but effect was significantly 
reversed by Haritaki and Madhu in comparison to 
positive control. The above effects of hyperlipidemic 
diet are indicative of impaired liver functions.  Most of 
these parameters were found to be reversed by 
Haritaki and Madhu combined group. Madhu given 
alone has no effect. The observed effect may be the 
result of the reversal of the hyperlipidemic diet 
induced changes or there may be a hepatoprotective 
component also. 
Serum urea 
Generally, Urea is produced from the catabolism of 
various muscle proteins and amino acids. This urea 
helps in the metabolism of nitrogen containing 
compounds, reabsorptionof water, carries 
nitrogenous waste and helps in the counter-current 
exchange system. Haritaki and Madhu show 
significantly reduced serum urea level compared with 
positive control group. This is indicative of impact on 
nitrogen metabolism.   
Effect on Serum Creatinine 
Generally, creatinine is a break down product of 
creatinine phosphate in muscle metabolism. Feeding 
of hyperlipidemic diet per se did not elevate serum 
creatine level. Effect on serum creatinine and serum 
urea indicates that this diet did not cause impairment 
of kidney function. Decrease observed may be due to 
down regulated metabolism of the serum creatine.  
This decrease was not affect by Haritaki and Madhu. 
Effect on blood sugar level 
Haritaki and Madhu show   reduced blood sugar level 
compared with positive control group. This effect was 
moderate and non-significant. This moderate effect 
may be useful to improve insulin sensitivity. The 
magnitude of alpha-glucosidase inhibition by 
chebulagic acid was greatly affected by its origin. 
Since this phytochemical is present in Haritaki it might 
have such an enzyme activity inhibitory effect. It may 
be useful in the treatment of obesity linked diabetes 
mellitus. 
Histological examination 
Histological examination of heart, kidney and liver 
showed that hyperlipidemic diet in the present study 
did not cause any significant degenerative changes in 
heart and kidney. However, significant changes were 
seen in liver in the form of fatty degeneration of the 
hepatocytes, marked cell depletion and mild to 
moderate cell infiltration. These degenerative changes 
were moderately reduced in standard and test drug 
administered groups. 
For any disease line of treatment depends on the 
basis of their Samprapti Vighatana. In the treatment 
of Medo Roga the drug needed to tackle the Vikruta 
Meda, Prakupita Vayu and Tikshna Jatharagni. Here 
Haritaki has Kashaya Pradhana Lavana Varjitha 
Pancharasa,  Ushnavirya, Madhuravipaka, 
Tridoshahara property, Ruksha Guna and Agnidipana, 
Medhya, Rasayana, Laghu, Anulomaka in nature
[3] 
and  
Madhu has Kashaya, Madhura Rasa and Ruksha, Guru 
Guna. It is Kapha, Pittahara, Chedaka and also 
Yogavahi.
[4]
 So combination of both Dravya fulfils the 
Guru Cha Apatarpana criteria for Samprapti 
Vighatana. Administration of Haritaki and Madhu 
tackle the Prakupita Vayu, Tikshna Jathragni and 
remove Prakrupita Meda by improving the Medo 
Dhatvagni. Ultimately the proper Upachaya of Medo 
Dhatu occur and remove the obstruction of Srotas.    
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CONCLUSION 
Dyslipidaemia is one of the major modifiable risk 
factors for atherosclerosis and its consequences. 
Haritaki and Madhu group showed statistically 
significant reduction in serum T. cholesterol, T.G., LDL, 
VLDL. In Haritaki and Madhu group there was 
reduction in body weight compare to positive control 
group. There was statistically significant difference 
between the results of Haritaki and Madhu group and 
positive control group. Haritaki and Madhu is very 
effective combination to prevent and cure the 
Dyslipidemia.   
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